Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 6/20 | 0.41 |
| ▸ | RAB9A | P51151 | 6/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | HTT | P42858 | 3/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | RAF1 | P04049 | 3/20 | 0.38 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.38 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.38 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23309165 | 0.82 | MEN1 (0.32) | MEN1KMT2AEGFRALDH1A1MAPK1 | |
| SCHEMBL23309191 | 0.82 | MEN1 (0.32) | MEN1KMT2AEGFRALDH1A1MAPK1 | |
| SCHEMBL21172194 | 0.77 | SHBG (0.38) | MEN1KMT2AEGFR | |
| SCHEMBL24168821 | 0.76 | L3MBTL1 (0.32) | — | |
| SCHEMBL84872 | 0.73 | MEN1 (0.48) | MEN1KMT2AEGFRALDH1A1MAPK1 | |
| SCHEMBL171117 | 0.73 | KMT2A (0.48) | MEN1KMT2AEGFRALDH1A1MAPK1 | |
| SCHEMBL21172389 | 0.73 | EGFR (0.30) | EGFR | |
| SCHEMBL13230275 | 0.73 | MEN1 (0.44) | MEN1KMT2AEGFRALDH1A1MAPK1 | |
| SCHEMBL21172193 | 0.72 | — | — | |
| SCHEMBL22140176 | 0.71 | MEN1 (0.47) | MEN1KMT2AEGFRALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239809-A1 | THERAPEUTIC AGENTS FOR ENHANCING EPITHELIAL AND/OR ENDOTHELIAL BARRIER FUNCTION | ARTUS THERAPEUTICS INC (US) | 2024-07-18 | — | — | US | disclosed |
| US-20230348501-A1 | HETEROARYL INHIBITORS OF PDE4 | Tetra Discovery Partners, LLC | 2023-11-02 | — | — | US | disclosed |
| US-11773077-B2 | Compounds containing carbon-carbon linker as GPR120 agonists | Piramal Enterprises Limited (IN) | 2023-10-03 | — | — | US | disclosed |
| US-11767334-B2 | Heteroaryl inhibitors of PDE4 | Tetra Discovery Partners, LLC (US) | 2023-09-26 | — | — | US | disclosed |
| US-20230279426-A1 | MODIFIED VIRAL COMPOSITIONS FOR VIRAL TRANSDUCTION | LYCIA THERAPEUTICS, INC. | 2023-09-07 | — | — | US | disclosed |
| US-20230279426-A1 | MODIFIED VIRAL COMPOSITIONS FOR VIRAL TRANSDUCTION | LYCIA THERAPEUTICS, INC. | 2023-09-07 | — | — | US | disclosed |
| US-20230257367-A1 | NOVEL THYROID HORMONE BETA RECEPTOR AGONIST | CHENGDU KANGHONG PHARMACEUTICAL CO., LTD. (CN) | 2023-08-17 | — | — | US | disclosed |
| US-11713324-B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2023-08-01 | — | — | US | disclosed |
| US-11713324-B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2023-08-01 | — | — | US | disclosed |
| US-20230226214-A1 | BIFUNCTIONAL BRIDGING COMPOSITIONS FOR VIRAL TRANSDUCTION | LYCIA THERAPEUTICS, INC. | 2023-07-20 | — | — | US | disclosed |
| US-H830-H | CONTAINING A DESILVERING ACCELERATOR RELEASING COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1990-10-02 | — | — | US | disclosed |
| US-4950764-A | HERBICIDES, BACTERICIDES, ANALGESICS, ANTIINFLAMMATORY AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1990-08-21 | — | — | US | disclosed |
| US-4942114-A | FLUORESCENT, REFLECTIVE | FUJI PHOTO FILM CO., LTD. (JP) | 1990-07-17 | — | — | US | disclosed |
| US-4939066-A | DEVELOPMENT INHIBITOR-RELEASING COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1990-07-03 | — | — | US | disclosed |
| US-4921785-A | Silver halide photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1990-05-01 | — | — | US | disclosed |
| US-4916047-A | POLYMERIC COMPOUND RELEASING USEFUL GROUP BY REDOX PROCESS TRIGGERED BY REDUCING AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1990-04-10 | — | — | US | disclosed |
| US-4886736-A | COUPLERS AND COMPOUND CAPABLE OF RELEASING PHOTOGRAPHICALLY USEFUL GROUP UPON REDUCTION | FUJI PHOTO FILM CO., LTD. (JP) | 1989-12-12 | — | — | US | disclosed |
| US-4783396-A | Silver halide photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1988-11-08 | — | — | US | disclosed |
| EP-0280252-A2 | Silver halide photographic material and method for forming super high contrast image therewith | FUJI PHOTO FILM CO., LTD. (JP) | 1988-08-31 | — | — | EP | disclosed |
| EP-0220746-A2 | Silver halide photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1987-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773077-B2 | Compounds containing carbon-carbon linker as GPR120 agonists | GPR180, GPR68, GPR88 | MEN1 4061/4885KMT2A 4492/4885EGFR 1520/4885 |
| US-20230348501-A1 | HETEROARYL INHIBITORS OF PDE4 | PDE4A, PDE4B, PDE4C | MEN1 4531/4885KMT2A 3408/4885EGFR 4836/4885 |
| US-11713324-B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | GNRHR, GHRHR, LHCGR | MEN1 566/4885KMT2A 1468/4885EGFR 1317/4885 |
| US-20230226214-A1 | BIFUNCTIONAL BRIDGING COMPOSITIONS FOR VIRAL TRANSDUCTION | HAVCR2, FCGR3B, FCGR2A | MEN1 1824/4885KMT2A 3875/4885EGFR 60/4885 |
| US-11767334-B2 | Heteroaryl inhibitors of PDE4 | PDE4A, PDE4B, PDE4C | MEN1 4531/4885KMT2A 3408/4885EGFR 4836/4885 |
| US-20240239809-A1 | THERAPEUTIC AGENTS FOR ENHANCING EPITHELIAL AND/OR ENDOTHELIAL BARRIER FUNCTION | LIPG, FABP2, EPCAM | MEN1 4530/4885KMT2A 4821/4885EGFR 614/4885 |
| US-20230257367-A1 | NOVEL THYROID HORMONE BETA RECEPTOR AGONIST | THRB, THRA, TSHR | MEN1 1680/4885KMT2A 2510/4885EGFR 268/4885 |
| US-20230279426-A1 | MODIFIED VIRAL COMPOSITIONS FOR VIRAL TRANSDUCTION | HAVCR2, ASGR1, FCGR3B | MEN1 2803/4885KMT2A 3255/4885EGFR 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.